3D Echo Characterization of Proportionate and Disproportionate Functional Mitral Regurgitation before and after

Sara Cimino1, Luciano Agati1, Domenico Filomena1

  • 1Department of Clinical, Internal, Anesthesiological and Cardiovascular Sciences, Sapienza University of Rome, Policlinico Umberto I, 00161 Rome, Italy.

Abstract

Insights

Patients with proportionate mitral regurgitation (P-MR) face worse outcomes after percutaneous mitral valve repair (PMVr) compared to disproportionate mitral regurgitation (D-MR) patients. The effective regurgitant orifice area/left ventricular end-diastolic volume (EROA/LVEDV) ratio is crucial for stratifying functional mitral regurgitation (FMR) risk.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Echocardiography

Background:

  • Long-term prognosis after percutaneous mitral valve repair (PMVr) for functional mitral regurgitation (FMR) remains uncertain.
  • A new classification divides FMR into proportionate (P-MR) and disproportionate (D-MR) based on the EROA/LVEDV ratio.
  • This study investigates the influence of this classification on PMVr efficacy.

Purpose of the Study:

  • To evaluate the impact of the P-MR/D-MR classification on the outcomes of PMVr.
  • To assess the prognostic value of the EROA/LVEDV ratio in FMR patients undergoing PMVr.

Main Methods:

  • Fifty-six patients with FMR undergoing PMVr were analyzed.
  • Patients were categorized into P-MR and D-MR groups based on the EROA/LVEDV ratio.
  • Echocardiographic parameters (including GLS) and clinical adverse events (CV death, HF rehospitalization) were assessed at 6 and 12 months.

Main Results:

  • D-MR patients exhibited distinct anatomical characteristics, including a more elliptical mitral valve annulus and preserved LV ejection fraction.
  • P-MR patients demonstrated a higher rate of MR recurrence at 6 months.
  • At 12 months, P-MR patients had significantly higher rates of cardiovascular death and heart failure rehospitalization (46% vs. 7%).

Conclusions:

  • Patients with P-MR experience significantly worse clinical outcomes following PMVr compared to D-MR patients.
  • The EROA/LVEDV ratio effectively stratifies FMR patients into prognostically distinct subgroups.
  • This classification aids in understanding mitral valve and left ventricular anatomical differences influencing PMVr success.

Related Concept Videos

Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
76
Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
69
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
45
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
42
Mitral Regurgitation IV: Nursing Management01:28

Mitral Regurgitation IV: Nursing Management

Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
113
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
62